HGH Holdings (SGX:5GZ) Piotroski F-Score: 5 (As of Jul. 18, 2026) — 17% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is HGH Holdings Piotroski F-Score?

HGH Holdings SGX:5GZ Piotroski F-Score is 5 as of Jul. 18, 2026, which is 17% below its 10-year median of 6.00. The stock has 2 warning signs investors should review. Among 2,969 Industrial Products companies, HGH Holdings ranks better than 56.55% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

HGH Holdings has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for HGH Holdings's Piotroski F-Score or its related term are showing as below:

SGX:5GZ' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 7
Current: 5

During the past 13 years, the highest Piotroski F-Score of HGH Holdings was 7. The lowest was 4. And the median was 6.

HGH Holdings  (SGX:5GZ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


HGH Holdings Piotroski F-Score Related Terms


HGH Holdings Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for HGH Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HGH Holdings Piotroski F-Score Chart

HGH Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 5.00 7.00 6.00 5.00

HGH Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 0.00 6.00 0.00 5.00

SGX:5GZ vs VRT, BE, HUBB: Piotroski F-Score Comparison

For the Electrical Equipment & Parts subindustry, HGH Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HGH Holdings Piotroski F-Score vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, HGH Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where HGH Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was S$5.22 Mil.
Cash Flow from Operations was S$-0.50 Mil.
Revenue was S$54.64 Mil.
Gross Profit was S$13.95 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (69.246 + 90.872) / 2 = S$80.059 Mil.
Total Assets at the begining of this year (Dec24) was S$69.25 Mil.
Long-Term Debt & Capital Lease Obligation was S$8.12 Mil.
Total Current Assets was S$34.23 Mil.
Total Current Liabilities was S$24.83 Mil.
Net Income was S$-0.20 Mil.

Revenue was S$21.32 Mil.
Gross Profit was S$6.08 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (64.437 + 69.246) / 2 = S$66.8415 Mil.
Total Assets at the begining of last year (Dec23) was S$64.44 Mil.
Long-Term Debt & Capital Lease Obligation was S$6.97 Mil.
Total Current Assets was S$13.47 Mil.
Total Current Liabilities was S$8.92 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

HGH Holdings's current Net Income (TTM) was 5.22. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

HGH Holdings's current Cash Flow from Operations (TTM) was -0.50. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=5.22/69.246
=0.07538342

ROA (Last Year)=Net Income/Total Assets (Dec23)
=-0.2/64.437
=-0.00310381

HGH Holdings's return on assets of this year was 0.07538342. HGH Holdings's return on assets of last year was -0.00310381. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

HGH Holdings's current Net Income (TTM) was 5.22. HGH Holdings's current Cash Flow from Operations (TTM) was -0.50. ==> -0.50 <= 5.22 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=8.124/80.059
=0.10147516

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=6.974/66.8415
=0.10433638

HGH Holdings's gearing of this year was 0.10147516. HGH Holdings's gearing of last year was 0.10433638. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=34.227/24.834
=1.37823146

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=13.465/8.924
=1.50885253

HGH Holdings's current ratio of this year was 1.37823146. HGH Holdings's current ratio of last year was 1.50885253. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

HGH Holdings's number of shares in issue this year was 1780.861. HGH Holdings's number of shares in issue last year was 1780.861. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=13.95/54.644
=0.25528878

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=6.077/21.318
=0.28506426

HGH Holdings's gross margin of this year was 0.25528878. HGH Holdings's gross margin of last year was 0.28506426. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=54.644/69.246
=0.78912861

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=21.318/64.437
=0.33083477

HGH Holdings's asset turnover of this year was 0.78912861. HGH Holdings's asset turnover of last year was 0.33083477. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+1+0+1+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

HGH Holdings has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
HGH Holdings (SGX:5GZ) has a Piotroski F-Score of 5 as of Jul. 18, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on HGH Holdings and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, HGH Holdings' Piotroski F-Score has ranged from 4.00 to 7.00. According to the industry distribution chart, HGH Holdings ranks #1290 out of 2969 companies in the Industrial Products industry, placing it in the top 43.4%.
Is HGH Holdings' Piotroski F-Score too high?
HGH Holdings' current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 7.00. The Industrial Products industry median Piotroski F-Score is 5.00. HGH Holdings' value of 5 is 0% at this industry median. Based on the distribution chart, HGH Holdings ranks #1290 out of 2969 companies in the Industrial Products industry, which is above the industry midpoint.
How does HGH Holdings' Piotroski F-Score compare to VRT and BE?
According to the Industrial Products industry distribution chart, HGH Holdings ranks #1290 out of 2969 companies for Piotroski F-Score. This puts HGH Holdings in the upper half of its industry. The industry median Piotroski F-Score is 5.00. HGH Holdings' value of 5 is 0% at this benchmark. Historically, HGH Holdings' own Piotroski F-Score has ranged from 4.00 to 7.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, HGH Holdings has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for an Industrial Products company?
The median Piotroski F-Score among Industrial Products companies is 5.00, based on 2,969 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HGH Holdings's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on HGH Holdings and its competitors. For the Industrial Products industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HGH Holdings's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HGH Holdings stock overvalued right now?
Based on GuruFocus' analysis, HGH Holdings (SGX:5GZ) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.04, compared to a current price of S$0.02 — trading 62.5% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Industrial Products industry median of 5.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For HGH Holdings (SGX:5GZ), the current Piotroski F-Score is 5 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HGH Holdings Business Description

Address 60 Benoi Road, No 03-02, Singapore, SGP, 629906
HGH Holdings Ltd, through its subsidiaries, is engaged in the supply and manufacturing of ready-mix concrete products; supply of precast concrete products; providing one-stop high value-added general warehousing and logistics services, industrial, office space for engineering, manufacturing, industrial training, and workers' dormitory facilities; and providing underground cable installation and road reinstatement services. Its segments include leasing and service income, the Manufacturing of Precast Concrete products, the Supply and Manufacturing of Ready-Mix Concrete products; and the provision of Underground Cable Installation and Road Reinstatement.